Format

Send to

Choose Destination
PLoS One. 2015 Dec 3;10(12):e0144448. doi: 10.1371/journal.pone.0144448. eCollection 2015.

Functional Metagenomics of the Bronchial Microbiome in COPD.

Author information

1
Fundació Parc Taulí, Sabadell, Spain.
2
CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain.
3
Universitat Autònoma de Barcelona, Esfera UAB, Barcelona, Spain.
4
Fundació Insitut d'Investigació Germans Trias i Pujol, Badalona, Spain.
5
Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO-Public Health), Valencia, Spain.
6
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
7
Evolutionary Genetics Unit, Institut Cavanilles de Biodiversitat i Biologia Evolutiva (ICBiBE), Universitat de València, Valencia, Spain.
8
Department of Respiratory Medicine, Hospital Universitari Parc Taulí, Sabadell, Spain.
9
Department of Microbiology, Hospital Universitari Parc Taulí, Sabadell, Spain.

Abstract

The course of chronic obstructive pulmonary disease (COPD) is frequently aggravated by exacerbations, and changes in the composition and activity of the microbiome may be implicated in their appearance. The aim of this study was to analyse the composition and the gene content of the microbial community in bronchial secretions of COPD patients in both stability and exacerbation. Taxonomic data were obtained by 16S rRNA gene amplification and pyrosequencing, and metabolic information through shotgun metagenomics, using the Metagenomics RAST server (MG-RAST), and the PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) programme, which predict metagenomes from 16S data. Eight severe COPD patients provided good quality sputum samples, and no significant differences in the relative abundance of any phyla and genera were found between stability and exacerbation. Bacterial biodiversity (Chao1 and Shannon indexes) did not show statistical differences and beta-diversity analysis (Bray-Curtis dissimilarity index) showed a similar microbial composition in the two clinical situations. Four functional categories showed statistically significant differences with MG-RAST at KEGG level 2: in exacerbation, Cell growth and Death and Transport and Catabolism decreased in abundance [1.6 (0.2-2.3) vs 3.6 (3.3-6.9), p = 0.012; and 1.8 (0-3.3) vs 3.6 (1.8-5.1), p = 0.025 respectively], while Cancer and Carbohydrate Metabolism increased [0.8 (0-1.5) vs 0 (0-0.5), p = 0.043; and 7 (6.4-9) vs 5.9 (6.3-6.1), p = 0.012 respectively]. In conclusion, the bronchial microbiome as a whole is not significantly modified when exacerbation symptoms appear in severe COPD patients, but its functional metabolic capabilities show significant changes in several pathways.

PMID:
26632844
PMCID:
PMC4669145
DOI:
10.1371/journal.pone.0144448
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center